It’s heavy going at times going through this study part funded by the WHO:
https://www.sciencedirect.com/science/article/pii/S0160412025002338
You can download a pdf copy from the site for free.
Here’s the end bit:
4.4.1. Final conclusions
The findings of this systematic review indicate that there is evidence that RF EMF exposure increases the incidence of cancer in experimental animals with the CoE being strongest for malignant heart schwannomas and gliomas.
Despite the high level of certainty that evidence of carcinogenicity in experimental animals may predict a carcinogenic hazard to humans, extrapolation of risk from cancer bioassays to humans is particularly complex for RF EMF. Without an understanding of the mechanism of the carcinogenicity of RF EMF the choice of exposure metric for risk extrapolation (whole body versus localized), intensity or cumulative exposure whether or not a monotonic dose–response holds for carcinogenic effects, and whether SAR is the appropriate dose metric for adverse effects induced by RF-EMF may be critical.
Besides the integration of the sensitivity domain adopted from the RoC, more work is needed to tailor the GRADE approach to assessing the CoE from animal cancer bioassays designed to identifying risks of environmental agents.
It’s my highlighting in bold.
Will the WHO now fund the further research asked for?